Tissue transglutaminase, a key enzyme involved in liver diseases

Jian Wu, Mark A Zern

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Ubiquitous tissue transglutaminase (tTG) is one member of the large transglutaminase (TG) family, which catalyze posttranslational modification of proteins by establishing ε(γ-glutamyl)lysine cross-linking and/or covalent incorporation of polyamines. The unique characteristics of tTG include: (1) possessing both cross-linking activity and GTPase activity; (2) functioning as a G protein; and (3) participating in the signal transduction of α1-adrenergic receptor coupling. A growing body of literature suggests that increased tTG levels in the cytosolic or nuclear compartments contribute to the apoptotic process, and lines of evidence exist that nuclear translocation and cross-linking of transcriptional factor Sp1 may represent the underlying mechanisms of these proapoptotic effects of tTG. Our studies indicate that tTG GTPase activation may be responsible for enhanced hepatocyte proliferation, whereas, its tTGase activity may cause increased apoptosis. Moreover, it appears that tTG cross-linking activity contributes to hepatic fibrogenesis in animal models and in human liver disease. Understanding the roles of tTG in the pathogenesis of liver disease could facilitate the development of new treatment regimens.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalHepatology Research
Volume29
Issue number1
DOIs
StatePublished - May 2004

Fingerprint

Liver Diseases
Enzymes
GTP Phosphohydrolases
Transglutaminases
Polyamines
Post Translational Protein Processing
transglutaminase 2
GTP-Binding Proteins
Adrenergic Receptors
Lysine
Hepatocytes
Signal Transduction
Animal Models
Apoptosis
Liver
Proteins

Keywords

  • Apoptosis
  • Fibrosis
  • Liver
  • Regeneration
  • Tissue transglutaminase

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Tissue transglutaminase, a key enzyme involved in liver diseases. / Wu, Jian; Zern, Mark A.

In: Hepatology Research, Vol. 29, No. 1, 05.2004, p. 1-8.

Research output: Contribution to journalArticle

Wu, Jian ; Zern, Mark A. / Tissue transglutaminase, a key enzyme involved in liver diseases. In: Hepatology Research. 2004 ; Vol. 29, No. 1. pp. 1-8.
@article{ddc35266217343be943289b62ccf3a06,
title = "Tissue transglutaminase, a key enzyme involved in liver diseases",
abstract = "Ubiquitous tissue transglutaminase (tTG) is one member of the large transglutaminase (TG) family, which catalyze posttranslational modification of proteins by establishing ε(γ-glutamyl)lysine cross-linking and/or covalent incorporation of polyamines. The unique characteristics of tTG include: (1) possessing both cross-linking activity and GTPase activity; (2) functioning as a G protein; and (3) participating in the signal transduction of α1-adrenergic receptor coupling. A growing body of literature suggests that increased tTG levels in the cytosolic or nuclear compartments contribute to the apoptotic process, and lines of evidence exist that nuclear translocation and cross-linking of transcriptional factor Sp1 may represent the underlying mechanisms of these proapoptotic effects of tTG. Our studies indicate that tTG GTPase activation may be responsible for enhanced hepatocyte proliferation, whereas, its tTGase activity may cause increased apoptosis. Moreover, it appears that tTG cross-linking activity contributes to hepatic fibrogenesis in animal models and in human liver disease. Understanding the roles of tTG in the pathogenesis of liver disease could facilitate the development of new treatment regimens.",
keywords = "Apoptosis, Fibrosis, Liver, Regeneration, Tissue transglutaminase",
author = "Jian Wu and Zern, {Mark A}",
year = "2004",
month = "5",
doi = "10.1016/j.hepres.2004.02.007",
language = "English (US)",
volume = "29",
pages = "1--8",
journal = "International Hepatology Communications",
issn = "0928-4346",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Tissue transglutaminase, a key enzyme involved in liver diseases

AU - Wu, Jian

AU - Zern, Mark A

PY - 2004/5

Y1 - 2004/5

N2 - Ubiquitous tissue transglutaminase (tTG) is one member of the large transglutaminase (TG) family, which catalyze posttranslational modification of proteins by establishing ε(γ-glutamyl)lysine cross-linking and/or covalent incorporation of polyamines. The unique characteristics of tTG include: (1) possessing both cross-linking activity and GTPase activity; (2) functioning as a G protein; and (3) participating in the signal transduction of α1-adrenergic receptor coupling. A growing body of literature suggests that increased tTG levels in the cytosolic or nuclear compartments contribute to the apoptotic process, and lines of evidence exist that nuclear translocation and cross-linking of transcriptional factor Sp1 may represent the underlying mechanisms of these proapoptotic effects of tTG. Our studies indicate that tTG GTPase activation may be responsible for enhanced hepatocyte proliferation, whereas, its tTGase activity may cause increased apoptosis. Moreover, it appears that tTG cross-linking activity contributes to hepatic fibrogenesis in animal models and in human liver disease. Understanding the roles of tTG in the pathogenesis of liver disease could facilitate the development of new treatment regimens.

AB - Ubiquitous tissue transglutaminase (tTG) is one member of the large transglutaminase (TG) family, which catalyze posttranslational modification of proteins by establishing ε(γ-glutamyl)lysine cross-linking and/or covalent incorporation of polyamines. The unique characteristics of tTG include: (1) possessing both cross-linking activity and GTPase activity; (2) functioning as a G protein; and (3) participating in the signal transduction of α1-adrenergic receptor coupling. A growing body of literature suggests that increased tTG levels in the cytosolic or nuclear compartments contribute to the apoptotic process, and lines of evidence exist that nuclear translocation and cross-linking of transcriptional factor Sp1 may represent the underlying mechanisms of these proapoptotic effects of tTG. Our studies indicate that tTG GTPase activation may be responsible for enhanced hepatocyte proliferation, whereas, its tTGase activity may cause increased apoptosis. Moreover, it appears that tTG cross-linking activity contributes to hepatic fibrogenesis in animal models and in human liver disease. Understanding the roles of tTG in the pathogenesis of liver disease could facilitate the development of new treatment regimens.

KW - Apoptosis

KW - Fibrosis

KW - Liver

KW - Regeneration

KW - Tissue transglutaminase

UR - http://www.scopus.com/inward/record.url?scp=2342624532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342624532&partnerID=8YFLogxK

U2 - 10.1016/j.hepres.2004.02.007

DO - 10.1016/j.hepres.2004.02.007

M3 - Article

AN - SCOPUS:2342624532

VL - 29

SP - 1

EP - 8

JO - International Hepatology Communications

JF - International Hepatology Communications

SN - 0928-4346

IS - 1

ER -